Medinova Diagnostic Service

38.60
-1.40
(-3.50%)
Market Cap
38.50 Cr
EPS
2.00
PE Ratio
21.05
Dividend Yield
0.00 %
52 Week High
51.05
52 Week Low
32.10
PB Ratio
-32.77
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,802.00
#1 23,422.40
47.59
#1 2,295.80
11.52
#1 362
81.24
55.07
987.70
10,137.39
72.33
568.60
20.11
120
35.77
47.02
1,650.80
8,465.49
55.93
1,216.80
4.59
129
15.38
48.25
895.10
4,743.44
52.56
581.30
8.63
70
25.58
68.17
697.30
2,251.57
30.10
636.40
25.65
57
49.23
38.79
1,651.90
1,417.77
30.29
86.70
25.47
32
58.82
45.62
248.80
791.45
#1 7.82
1,436.10
35.04
6
-1,081.25
47.26
266.95
189.57
16.85
63.00
#1 248.07
7
133.33
26.91
114.90
80.00
62.53
36.90
6.34
1
0.00
44.70
59.19
60.90
75.98
13.60
-8.11
-3
#1 142.86
36.20
Growth Rate
Revenue Growth
1.96 %
Net Income Growth
17.65 %
Cash Flow Change
88.03 %
ROE
97.32 %
ROCE
-51.70 %
EBITDA Margin (Avg.)
4.01 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
2
1
2
2
3
2
2
2
4
2
2
2
4
2
3
2
4
2
2
2
2
2
5
4
3
5
3
3
3
3
3
2
3
2
3
2
3
3
3
2
3
Expenses
5
2
2
2
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
2
1
4
3
2
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
EBITDA
-2
-0
0
-0
0
0
0
-0
1
-0
0
0
2
0
1
0
2
0
0
0
0
0
1
1
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Operating Profit %
-159 %
-22 %
6 %
-4 %
7 %
14 %
4 %
-6 %
-11 %
-3 %
6 %
19 %
4 %
11 %
19 %
12 %
16 %
17 %
5 %
23 %
18 %
11 %
19 %
29 %
30 %
33 %
26 %
24 %
26 %
24 %
24 %
22 %
33 %
22 %
32 %
25 %
30 %
28 %
31 %
29 %
33 %
Depreciation
1
0
0
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-3
-0
-0
-1
-1
-1
-1
-1
0
-1
-1
-0
1
-0
-0
-0
2
-0
-0
0
0
-0
1
1
1
1
1
0
1
0
0
0
1
0
1
0
1
1
1
1
1
Tax
-1
0
0
0
-0
0
0
0
-0
0
0
0
-0
0
0
0
0
0
0
0
-0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
-3
-0
-0
-1
-1
-1
-1
-1
1
-1
-1
-0
1
-0
-0
-0
1
-0
-0
0
0
-0
1
1
1
1
1
0
0
0
0
0
1
0
1
0
1
0
1
0
1
EPS in ₹
-2.63
-0.40
-0.15
-0.79
-0.69
-0.53
-0.66
-0.96
0.71
-0.63
-0.46
-0.23
1.00
-0.14
-0.07
-0.24
1.25
-0.09
-0.25
0.03
0.05
-0.04
0.67
0.88
0.52
1.03
0.54
0.36
0.35
0.30
0.36
0.24
0.78
0.33
0.67
0.40
0.60
0.42
0.50
0.38
0.60

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
10
13
9
6
5
4
4
4
5
5
Fixed Assets
7
9
7
5
3
2
2
2
2
2
Current Assets
3
2
1
1
1
1
2
2
2
3
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
4
4
2
2
1
2
3
3
3
4
Total Liabilities
10
13
9
6
5
4
4
4
5
5
Current Liabilities
15
13
11
10
9
9
8
5
4
3
Non Current Liabilities
2
8
7
6
5
5
4
6
6
5
Total Equity
-7
-8
-10
-10
-9
-9
-8
-7
-5
-3
Reserve & Surplus
-16
-18
-20
-20
-19
-19
-17
-17
-15
-13
Share Capital
10
10
10
10
10
10
10
10
10
10

Cash Flow

Cash Flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
-0
0
0
-0
0
1
Investing Activities
-5
-0
0
-0
-0
-0
-2
-0
-0
Operating Activities
-1
0
1
1
1
2
1
1
3
Financing Activities
5
0
-2
-1
-1
-1
0
-1
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
62.14 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
36.29 %
36.05 %
36.06 %
36.19 %
36.14 %
36.01 %
36.03 %
35.96 %
35.94 %
36.00 %
36.02 %
35.49 %
35.58 %
36.09 %
36.29 %
35.90 %
35.97 %
Others
1.57 %
1.82 %
1.80 %
1.67 %
1.73 %
1.85 %
1.83 %
1.91 %
1.93 %
1.86 %
1.84 %
2.38 %
2.28 %
1.77 %
1.58 %
1.97 %
1.89 %
No of Share Holders
9,494
9,582
9,804
9,906
9,860
9,900
9,937
9,972
9,926
9,921
10,041
10,205
10,295
10,544
10,730
10,931
10,847

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
03 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 May 2025 41.05 42.18
25 Apr 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
25 Apr 2025 38.02 41.17
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jan 2025 39.00 35.75
29 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Oct 2024 38.45 38.00
03 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
03 Sept 2024 35.00 37.36

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
Results - For FY 2024-255 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report10 days ago
Board Meeting Intimation for Approval Of Audited Financial Results Of The CompanyApr 26, 2025
Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingApr 25, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 05, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2025
Notice Of Meeting Of The Equity Shareholders Of Medinova Diagnostic Services Limited To Be Convened As Per The Directions Provided In The Order Of The HonBle National Company Law TribunalMar 25, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Feb 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2025
Integrated Filing (Financial)Jan 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 30, 2025
Board Meeting Outcome for Outcome Of Board MeetingJan 30, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 23, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024 Among Other Corporate Matters.Jan 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Receipt Of Observation Letter From BSE Limited With No Adverse Observations For The Scheme Of AmalgamationDec 07, 2024
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Nov 16, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th October 2024Oct 29, 2024
Un-Audited Financial Results For The Quarter Ended September 30, 2024Oct 29, 2024
Board Meeting Intimation for To Consider And Approve The Standalone And Consolidated Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2024; And Other Corporate MattersOct 19, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 03, 2024
Closure of Trading WindowSep 25, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 04, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 03, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 10, 2024
Reg. 34 (1) Annual Report.Aug 09, 2024
Notice Of 31St Annual General Meeting Of The CompanyAug 09, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2024
Intimation Of 31St Annual General Meeting (AGM) And Cut-Off Date For E-Voting And AGM.Aug 08, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementJul 30, 2024
Unaudited Financial Results For The Quarter Ended June 30, 2024Jul 30, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th July 2024Jul 30, 2024
Board Meeting Intimation for Regulation 29 Of The SEBI (LODR) Reg, 2015Jul 23, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 11, 2024
Closure of Trading WindowJun 27, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 26, 2024
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 26, 2024
Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, ('SEBI Listing Regulations') - Outcome Of The Board Meeting Of Medinova Diagnostic Services Limited Held On Wednesday, June 26, 2024Jun 26, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 21, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementJun 01, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 27, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 26, 2024
Announcement under Regulation 30 (LODR)-RetirementApr 26, 2024
Audited Financial Results For The Quarter And Financial Year Ended 31St March 2024Apr 26, 2024

Technical Indicators

RSI(14)
Neutral
49.69
ATR(14)
Volatile
2.35
STOCH(9,6)
Neutral
44.78
STOCH RSI(14)
Neutral
35.45
MACD(12,26)
Bearish
-0.04
ADX(14)
Weak Trend
19.90
UO(9)
Bearish
38.95
ROC(12)
Downtrend And Accelerating
-2.44
WillR(14)
Neutral
-74.48